ApolloMed Q3 revenue $227.1M (+26% YoY), raises FY guidance; appoints Brandon Sim Co-CEO

Astrana Health, Inc.

2021-Q3 EPS reported $1.33 revenue$578,815,000

Q3 revenue $227.1M (+26% YoY); EPS diluted $0.74 (up 64%); net income attributable to ApolloMed $34.3M (up 105%).
FY2021 guidance raised: revenue $751.5-758.5M, net income attributable $71.5-73.5M, adjusted EBITDA $168.5-170.5M.
Brandon Sim appointed Co-CEO effective Nov 2; Kenneth Sim steps down as Co-CEO but remains Executive Chairman.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Kenneth Sim

Executive Chairman

ASTH · Astrana Health, Inc.

Effective: 2021-11-02
Successor: Brandon Sim
Filed: November 4, 2021, 7:59 PM ET

In connection with Brandon Sim’s appointment, Kenneth Sim, M.D. will step out of his current role as Co-Chief Executive Officer. He will continue to serve as the Company’s Executive Chairman.

Role change

Brandon Sim

Co-Chief Executive Officer

ASTH · Astrana Health, Inc.

Effective: 2021-11-02
Filed: November 4, 2021, 7:59 PM ET

On November 2, 2021, the Company appointed Brandon Sim as the Company’s Co-Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kenneth Sim changed role as Executive Chairman at Astrana Health, Inc..

Action: stepped down
Role: Executive Chairman

Exact text from the filing

In connection with Brandon Sim’s appointment, Kenneth Sim, M.D. will step out of his current role as Co-Chief Executive Officer. He will continue to serve as the Company’s Executive Chairman.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Brandon Sim was appointed as Co-Chief Executive Officer at Astrana Health, Inc..

Action: appointed
Role: Co-Chief Executive Officer

Exact text from the filing

On November 2, 2021, the Company appointed Brandon Sim as the Company’s Co-Chief Executive Officer.

View on SEC.gov

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-21-021770

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.